Nelarabine (Arranon) (Nelarabine Injection) 5 mg/mL

Nelarabine injection 5 mg/mL is a chemotherapy medication used to treat certain cancers. It belongs to a class of drugs known as antimetabolites. This sterile solution is administered by healthcare professionals. Find reliable information on uses, effects, and safety here.

Strength

5 mg/mL

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nelarabine injection is primarily used to treat T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in patients whose cancer has not responded to other treatments or has returned after treatment. It works by interfering with the growth of cancer cells. Healthcare providers may also consider it for other conditions within this therapeutic class. Always consult a medical professional for personalized advice.

Side Effects

Nelarabine may cause side effects such as fatigue, nausea, or low blood cell counts. Some patients report dizziness or headaches during treatment. These effects vary by individual and are typically monitored by a healthcare team. Keeping a symptom diary can help track changes during therapy.

Precautions & Warnings

This medication should only be handled and administered by trained healthcare providers. Patients should report any unusual symptoms, infections, or bleeding immediately. Staying hydrated and avoiding close contact with sick individuals is recommended. Follow all safety guidelines provided by your medical team.

Avoid Interactions

Nelarabine may interact with other chemotherapy drugs, medications affecting the immune system, or drugs metabolized by certain liver enzymes. Alcohol and herbal supplements should be used cautiously. Always inform your doctor about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Nelarabine injection is used to treat certain types of T-cell leukemia and lymphoma.

It is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common side effects include fatigue, nausea, and low blood cell counts.

Consult your doctor before taking any other medications or supplements during treatment.

Nelarabine may harm an unborn baby; discuss risks and contraception with your healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.